Encouraging results from son of Ibrutinib stud... - CLL Support

CLL Support

22,493 members38,640 posts

Encouraging results from son of Ibrutinib studies (Acalabrutinib/Calquence)

AdrianUK profile image
19 Replies

In case you need any more persuasion that we are in exiting times for the future of CLL, read this article about the exciting results of a drug which all being well may one day replace ibrutinib. Not every promising drug gets all the way through. But when you have a drug with a similar target but hopefully fewer side effects the likelihood of success improves.

cancer.osu.edu/news-and-med...

Title changed so information on Acalabrutinib/Calquence can be found via Search - Admin

Written by
AdrianUK profile image
AdrianUK
To view profiles and participate in discussions please or .
Read more about...
19 Replies
Justasheet1 profile image
Justasheet1

It’s already approved for Mantle cell cancer. I’m hoping we’re next this year.

I’m guessing if you’re intolerant to Ibrutinib it will be the go to drug.

Ladydi49 profile image
Ladydi49 in reply to Justasheet1

Do you know the name of the drug?

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to Ladydi49

Calquence (acalabrutinib) should be available in the U.S. fall 2018, but no sure bets.

~chris

DaleFL profile image
DaleFL in reply to Cllcanada

For CLL?

larrymarion profile image
larrymarion in reply to DaleFL

while not officially approved for CLL by the FDA, it is being prescribed by many docs for patients with R/R CLL who are having problems with ibrutinib. And some insurance companies are approving the Rx for CLL, too.

bhayes84 profile image
bhayes84 in reply to Cllcanada

Why isn't it available now Chris?

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to bhayes84

Its up to the drug company to start the process for approval, likely they are waiting for more data. Since its already been reviewed by the FDA for safety concerns in the MCL approval, it's easier and faster to get a second indication, CLL second line approved.

I don't know were things stand at the moment, Astrazeneca hasn't given any indications either...

~chris

Ibrutinib works well for me so far, but love having another drug on the shelf just in case. Thanks, Sally

Kwenda profile image
Kwenda

Good news obviously, less side effects such as AF..

BUT will it be affordable, and can NICE agree a price in the UK that the NHS will also agree to.???

Dick

Justasheet1 profile image
Justasheet1 in reply to Kwenda

Pricing should be in line with Ibrutinib.

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to Justasheet1

Second in class drugs have a rough time, some like ofatumumab fail...simply due to cost. I hope Calquence (acalabrutinib) comes to market at about $90,000 annually, compared to Imbruvica (ibrutinib) at $148,000 it will be a bargain.. win over funders and insurance companies, get it in broad use, then worry about price.

~chris

AdrianUK profile image
AdrianUK in reply to Cllcanada

Getting the pricing strategy right will be crucial for them. What’s the price for their current indication?

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to AdrianUK

100mg BID, for MCL

The wholesale acquisition cost for Calquence is $14,260 per month, certainly comparable to Imbruvica (ibrutinib), but who knows...

I have no idea of the market size... drug pricing in the U.S. is largely smoke and mirrors.

professionals.optumrx.com/c...

Also see

reference.medscape.com/drug...

~chris

Ladydi49 profile image
Ladydi49

I hope so. I can't take Ibrutinib due to mild cardiac issues so my choices are Bendamustine with Rituxan or Gazyva. Sadly, I think Ibrutinib would work for me😕

DaleFL profile image
DaleFL in reply to Ladydi49

Hang in there. It will come.

SMS-not-cll profile image
SMS-not-cll

You did it again, AdianUK! Thanks for sending this link.

Our CLL treatments keep improving to give us a brighter future.

Wishing good days and good health to all.

SMS

mgh348 profile image
mgh348

I have been on acalabrutinib for 18 months very successfully with few side effects. Truly has been a blessing.

Corkyrissa profile image
Corkyrissa in reply to mgh348

Does your insurance pay for Acalabrutinib or are u on clinical trial? What are the side effects.? I had been on ibrutinib for 19 months and dr stopped it because I’m being monitored for Afib now. Ty

mgh348 profile image
mgh348 in reply to Corkyrissa

I'm on a clinical trial at Mayo in Jacksonville. I had headaches and some mild diarrhea for a few weeks. An inflamed finger joint and achy knees for a few months. Hot flashes and blood pressure spikes in the middle of the night, but not sure what was causing them. Now on BP meds and they have stopped.

You may also like...

Changing from ibrutinib to acalabrutinib

are all symptoms of ibrutinib side effects, and that switching to acalabrutinib may solve the...

Switching from acalabrutinib to ibrutinib

shift from acalabrutinib to ibrutinib. Anyone here who did the same. Bit worrired :(

One Year Anniversary on Acalabrutinib (Calquence)

have reached my one year anniversary being on Acalabrutinib!…..how quickly that year has gone 😅....

Holding Calquence (acalabrutinib) for epidural injection.

seem to vary about the length of time to hold calquence for an epidural injection (L3-4 facet joint...

Anyone taking calquence (acalabrutinib)?

back on it. My doctor wants me to take calquence (acalabrutinib). However, I am even afraid of that...